Tuesday, September 2, 2014   

Novartis bosses in Japan shown the door
(04-03 14:03)

Swiss pharmaceutical giant Novartis said it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.
David Epstein, the head of the firm's pharmaceutical division, told a news briefing in Tokyo that the senior managers “resigned, they are out of the company,’’ adding that “this kind of behavior is unacceptable and a clear violation of our code of conduct''.
--AFP
   
Other Business breaking news:
Alipay, Huawei to promote mobile fingerprint payment (09-01 18:19)
Sony founder nephew to head PlayStation unit (09-01 17:27)
Microsoft demanded to explain over monopoly accusations (09-01 17:15)
German machine-tool orders stagnate in July (09-01 16:29)
Novartis Japan admits concealing drug side effects (09-01 16:28)
Heineken says selling Mexican packaging business (09-01 16:27)
European stocks mixed at open (09-01 16:16)
Hang Seng, Shanghai finish higher (09-01 16:14)
Macau gaming revenue down in August (09-01 15:29)
Germany runs up surplus in first half (09-01 15:08)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.